Lehrstuhl für Strahlentherapie

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells (2016) Derer A, Spiljar M, Baeumler M, Hecht M, Fietkau R, Frey B, Gaipl U Journal article Impact of radiotherapy and chemotherapy on PD-L1 and EGF-R expression in melanoma and glioblastoma cells (2016) Bäumler M, Spiljar M, Frey B, Fietkau R, Gaipl U, Derer A Conference contribution, Abstract of a poster Combination of Markerless Surrogates for Motion Estimation in Radiation Therapy (2016) Geimer T, Unberath M, Taubmann O, Bert C, Maier A Conference contribution Real-Time Respiratory Motion Analysis Using 4-D Shape Priors (2016) Wasza J, Fischer P, Leutheuser H, Oefner T, Bert C, Maier A, Hornegger J Journal article Differences in Dose Coverage and Uniformity in Fractionated High-Dose-Rate Interstitial Breast Brachytherapy Based on EMT Measurements (2016) Kellermeier M, Hofmann B, Strnad V, Bert C Conference contribution Response to 6 cycles of chemotherapy with FOLFIRINOX is predictive of overall survival in patients with locally advanced unresectable pancreatic cancer (2016) Haderlein M, Lubgan D, Lettmaier S, Semrau S, Wolf W, Golcher H, Hohenberger W, Fietkau R Conference contribution Effective long-term local results and prognostic factors after fractionated stereotactic radiotherapy of 257 intracranial meningeoma (2016) Lubgan D, Rutzner S, Semrau S, Lambrecht U, Roessler K, Buchfelder M, Fietkau R Conference contribution Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial) (2016) Hecht M, Hahn D, Beutner D, Reichert D, Goehler T, Wurm R, Welslau M, et al. Conference contribution Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial) (2016) Hecht M, Hahn D, Beutner D, Reichert D, Goehler T, Wurm R, Welslau M, et al. Conference contribution Tumor infiltrating cells - cell-to-cell distances enable differentiation between functionally active and suppressed inflammatory cells (2016) Distel L, Nagl S, Fietkau R, Haas M Conference contribution